Article

Rapid Recovery in Six Patients with COVID-19 Respiratory Failure after Treatment with Vasoactive Intestinal Peptide

2020-08-28

Abstract excerpt

Background: Vasoactive Intestinal Peptide (VIP) is known to bind to and protect the Alveolar Type II cell by blocking replication of the SARS-CoV-2 virus, upregulating surfactant production, blocking apoptosis, and blocking cytokine effects. RLF-100 (Aviptadil), a synthetic form of Vasoactive Intestinal Peptide (VIP) has been granted Fast Track Designation and is currently in phase 2/3 placebo-controlled trials. F...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 02ebe7b5-4e87-54da-a3a3-9a03cd22c834
DOI: 10.20944/preprints202008.0640.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapid Recovery in Six Patients with COVID-19 Respiratory Failure after Treatment with Vasoactive Intestinal PeptideDOI 10.20944/preprints202008.0640.v1Read

Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal PeptideSemantic proximity Read

Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.Semantic proximity Read

Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19.Semantic proximity Read

On whether therapeutic plasma exchange is an effective cure against severe/critical COVID-19 pneumoniaSemantic proximity Read

Supportive Management and Interventions for Respiratory Failure Due to SARS-CoV-2.Semantic proximity Read

A phase 2 study of the inhaled pan-JAK inhibitor TD-0903 in severe COVID-19: Part 1Semantic proximity Read

Inhaled nitric oxide use in COVID19-induced hypoxemic respiratory failureSemantic proximity Read

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialSemantic proximity Read

207 Days of Veno-Venous Extracorporeal Membrane Oxygenation Support for Severe COVID-19 Prior to Successful Lung Transplant: A Case ReportSemantic proximity Read

One-Year Outcomes in Patients Who Survived COVID-19-Related Acute Respiratory Distress Syndrome (ARDS): Pulmonary Function Tests (PFTs), Oxygen Requirement, and Quality of Life (QoL)Semantic proximity Read

Current knowledge of acute lung injury and acute respiratory distress syndrome.Semantic proximity Read

Clinical Outcomes of Implementing Two Management Protocols for Acute Respiratory Distress Patients with COVID-19: A Randomized Controlled TrialSemantic proximity Read